News from berg A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

Jun 04, 2018, 04:53 ETBERG Showcases New Clinical Data on BPM 31510 at ASCO 2018

BERG, LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today presented in a poster...


May 23, 2018, 07:34 ETBERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

BERG, LLC, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced that the U.S....


Apr 17, 2018, 08:16 ETBERG Announces Data Presentations at AACR 2018 Validating Novel Prostate Cancer Biomarkers and Clinical Activity of BPM 31510 Across Several Metabolic Cancer Types

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of 10 abstracts ...


Apr 04, 2018, 02:00 ETBERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the dosing of the first patient...


Jan 22, 2018, 09:00 ETBERG Announces FDA Orphan-Drug Designation of BPM31510 for the Treatment of Pancreatic Cancer

BERG, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the U.S. Food and...


Dec 13, 2017, 08:00 ETNew Research Partnership will Leverage BERG Interrogative Biology® Platform and Identify Novel Biomarker and Targets for Diagnosis and Treatment of Alzheimer's Disease

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, Massachusetts General Hospital (MGH), and...


Oct 30, 2017, 09:00 ETBERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

BERG, a biopharmaceutical company that merges biology with technology, today announced a new research effort with Sanofi Pasteur, the influenza...


Oct 27, 2017, 09:00 ETBERG Honored with Partner in Progress Award from DEBRA of America at Annual Benefit for Rare Disease Epidermolysis Bullosa (EB)

BERG, a biopharmaceutical company that merges biology with technology, today announced that the Company was honored with a Partners in Progress Award ...


Sep 19, 2017, 08:00 ETBERG Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical...


Sep 11, 2017, 09:00 ETBERG Presents Key Clinical Data at ESMO 2017 on BPM 31510 for Advanced Pancreatic Cancer Patients and BPM 31543 for Preventing Hair-Loss in Patients Treated With Chemotherapy

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced two poster presentations showing ...


Aug 28, 2017, 12:00 ETBERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat Neurological Disorders such as Parkinson's Disease

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced a research collaboration with...


May 15, 2017, 09:00 ETBERG Announces New Partnership with debra of America to Tackle Epidermolysis Bullosa-a Rare Genetic Tissue Disorder

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced they have entered...


Apr 03, 2017, 09:00 ETBERG Announces BPM 31510 Data Presentations at 2017 AACR in Immuno-Oncology, Glioblastoma Mutiforme, Pancreatic Cancers and Novel Prostate Cancer Biomarker Panel

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced seven poster...


Mar 27, 2017, 11:35 ETNew Data Published in Nature Medicine from Joslin Diabetes Center Demonstrates the Importance of Interrogating Human Biology

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that the company's ...


Feb 15, 2017, 08:04 ETBERG Initiates Phase I/II Monotherapy Trial of BPM 31510-IV in Patients with Glioblastoma Multiforme (GBM)

BERG LLC, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Feb 07, 2017, 08:02 ETBERG Announces Appointment of Titus Plattel as Chief Operating Officer

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced the appointment of ...


Jan 12, 2017, 12:00 ETBERG Enters into Multi-Year Agreement with BD for Next-Generation Analytics in Healthcare IT

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, announced a multi-year agreement...


Nov 14, 2016, 01:13 ETBERG Presents Data Uncovering a Novel Contributor to Parkinson's Disease at Society for Neuroscience 2016 Meeting

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today unveiled data from a recent...


Oct 31, 2016, 08:57 ETBERG, The Icahn School of Medicine at Mount Sinai to host "Fast Track" event at Fast Company's Second Annual Innovation Festival 2016

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, and the Icahn School of Medicine...


Oct 24, 2016, 09:04 ETBERG Expands Research Collaboration with Department of Defense and Walter Reed National Military Medical Center to Advance Precision Medicine for Breast Cancer Patients

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Aug 17, 2016, 02:17 ETBERG Strengthens Financial Leadership And Expands Board Of Directors

BERG, a technology-based biopharmaceutical company uncovering health solutions through a data-driven, systems biological research approach, today...


Jul 28, 2016, 05:38 ETBERG Promotes Coveney To Vice President Of Finance And Controller

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced the promotion of...


Jun 05, 2016, 11:06 ETBERG Announces Clinical Trial Data Presentations Of BPM 31510 In Advanced Solid Tumors And BPM 31543 For Prevention Of Chemotherapy-Induced Alopecia At American Society of Clinical Oncology Annual Meeting

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it will...


Apr 27, 2016, 10:00 ETBERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced that it has...


Apr 18, 2016, 10:46 ETBERG Announces BPM31510 Data Presentations At 2016 AACR Annual Meeting

BERG, a biopharmaceutical company uncovering health solutions through a data-driven, biological research approach, today announced five poster...